ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 64. Num. 8.
Pages 729-730 (August 2011)

Vascular Risk, Diabetes, and the Ankle-Brachial Index. Response

Riesgo vascular, diabetes e índice tobillo-brazo. Respuesta

José M. Baena-DíezabMaría T. AlzamoracdeRosa ForéscGuillem Perae
Rev Esp Cardiol. 2011;64:72910.1016/j.rec.2011.03.029
Pedro Valdivielso, José Mancera-Romero, Miguel Angel Sánchez-Chaparro

Options

To the Editor,

We would like to thank Valdivieso et al.1 for their interesting comments on the article by our ARTPER research group published in Revista Española de Cardiología.

With regard to a possible distortion of results caused by including patients with diabetes, we do not believe this constitutes an important limitation. The same could be said about the inclusion of patients with high blood pressure who, due to their higher cardiovascular risk, would also more frequently receive antihypertensive treatments and possibly–statins or antiplatelet agents. In fact, risk attributable to high blood pressure is greater than that of diabetes, as the magnitude of the effect does not differ excessively but prevalence is greater.2, 3

We agree that ankle-brachial index (ABI) measurement is of less clinical interest in low-risk than in intermediate-risk patients. Fortunately, there is a tool (REASON) that prioritizes ABI use, developed by the HERMES group and our own ARTPER group.4 To date, the Inter-society Consensus (TASC II) recommended measuring ABI in asymptomatic patients aged 50-69 years with diabetes or a history of smoking, at 70 years and older, and when cardiovascular risk is 10% to 20%.4 The REASON tool–which has been constructed and validated–establishes a score as a function of the risk factor profile to identify patients with a high probability of having ABI <0.9; it has 85.2% sensitivity, similar to TASC II, and 47.2% specificity, greater than TASC II (38.3%).4 How often ABI should be measured and/or repeated remains to be determined. This will require cohort follow-up studies and the consensus of groups of experts.

.

Corresponding author: jbaena@imim.es

Bibliography
[1]
Baena-Díez JM, Alzamora MT, Forés R, Pera G, Torán P, Sorribes, et al..
El índice tobillo-brazo mejora la clasificación del riesgo cardiovascular: estudio ARTPER/PERART..
Rev Esp Cardiol. , (2011), 64 pp. 186-192
[2]
Alzamora MT, Forés R, Baena-Díez JM, Pera G, Toran P, Sorribes M, et al..
The peripheral arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population..
BMC Public Health. , (2010), 10 pp. 38
[3]
Ramos R, Quesada M, Solanas P, Subirana I, Sala J, Vila J, et al..
Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk..
Eur J Vasc Endovasc Surg. , (2009), 38 pp. 305-311
[4]
Ramos R, Baena-Díez JM, Quesada M, Solanas P, Subirana I, Sala J, et al..
Derivation and validation of REASON: a risk score identifying candidates to screen for peripheral arterial disease using ankle brachial index..
Atherosclerosis. , (2011), 214 pp. 474-479
Are you a healthcare professional authorized to prescribe or dispense medications?